Journal of Gastrointestinal Surgery

, Volume 21, Issue 2, pp 312–320 | Cite as

Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma

  • Shenghua Hao
  • Ping Fan
  • Shaofei Chen
  • Caixue Tu
  • Chidan Wan
Original Article

Abstract

Background and Objectives

Intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (HCC) includes intrahepatic metastasis (IM) and multicenter occurrence (MO). The risk factors for these two types of intrahepatic recurrence have not been well defined.

Methods

The type of intrahepatic recurrence was determined based on histopathological features of 93 HCC patients who underwent a repeat hepatectomy for recurrent HCC. Various clinical and pathological factors were analyzed to define distinct risk factors for different types of intrahepatic recurrence.

Results

The recurrence rates at 1, 2, 3, 5, and 8 years postoperatively were 22.4, 42.9, 61.2, 85.7, and 100 %, respectively, in patients with IM and 5.0, 25.0, 45.5, 67.5, and 100 %, respectively, in patients with MO (p = 0.005). A total of 16 clinical and pathological factors were tested in univariable and multivariable analyses. We found that large-size tumor (>5 cm), multiple tumors (two or more), and vascular invasion were significantly associated with IM recurrence, and liver cirrhosis and Ishak hepatic inflammatory activity were highly associated with MO recurrence. In addition, blood transfusion and a high hepatitis B virus (HBV)-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.

Conclusions

IM and MO recurrences were associated with distinct risk factors, while blood transfusion and high HBV-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.

Keywords

Hepatocellular carcinoma Intrahepatic metastasis Multicenter occurrence Risk factor Recurrence 

Notes

Acknowledgments

We thank Dr. Sheng Wei, at the School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, for his assistance in the statistical analysis of this manuscript.

Author Contributions

Shenghua Hao designed, drafted, and revised the study critically for important intellectual content; Ping Fan acquired the data and drafted the study; Shaofei Chen analyzed the data and drafted the study; Caixue Tu interpreted the data and drafted the study; and Chidan Wan analyzed and revised the study critically for important intellectual content. All of the authors have approved the final version for publication and agreed to be accountable for all aspects of the study.

Compliance with Ethical Standards

This study was approved by the review committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.

Conflict of Interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J SurgOncol 2004, 85:36–41.Google Scholar
  2. 2.
    Chen PJ, Chen DS, Lai MY, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology. 1989;96:527–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, Shirabe K, Nishizaki K, Sugimachi K. Prognosis of recurrent hepatocellularcarcinoma: a 10-year surgical experience in Japan, Gastroenterology 1996;111:720–726.CrossRefPubMedGoogle Scholar
  4. 4.
    Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Tkayama T, Kawasaki S. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, Sakamoto M, Hirohashi S: Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer 1995;75:444–450.CrossRefPubMedGoogle Scholar
  6. 6.
    Saeki R, Nagai H, Kaneko S, Unoura M, Yamanaka N, Okamoto E, Kobayashi K, Matsubara K: Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol 2000;33:99–105.CrossRefPubMedGoogle Scholar
  7. 7.
    Friemel J, Rechsteiner M, Frick L, Böhm F, Struckmann K, Egger M, Moch H, Heikenwalder M, Weber A: Intratumor heterogeneity in hepatocellular carcinoma. Clin Cancer Res 2015;21:1951–1961.CrossRefPubMedGoogle Scholar
  8. 8.
    Li Q, Wang J,. Juzi JT, Sun Y, Zheng H, Cui YL, Li HX, Hao XS. Clonality Analysis for Multicentric Origin and Intrahepatic Metastasis in Recurrent and Primary Hepatocellular Carcinoma. J Gastrointest Surg 2008;12:1540–1547.CrossRefPubMedGoogle Scholar
  9. 9.
    Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7: 462–503.CrossRefPubMedGoogle Scholar
  10. 10.
    Greene FL, Page DL, Fleming ID, et al. (6th eds.). “In AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual.” New York: Springer: New York, 2002.Google Scholar
  11. 11.
    Arii S, Monden K, Niwano M, Furutani M, Mori A, Mizumoto M, Imamura M. Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg.1998;5:86–92.CrossRefPubMedGoogle Scholar
  12. 12.
    Matsuda M, Fujii H, Kono H, Matsumoto Y. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg. 2001;8:353–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Feo F, Pascale RM. Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?. Ann Transl Med 2015;3(1):4–8.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Portolani N, Coniglio A, Ghidoni S, Giovanelli M, BenettiA, Tiberio GA, Giulini SM. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229–35.Google Scholar
  15. 15.
    Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, et al. Liver resection for transplantable hepatocellularcarcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009;250:738–746.Google Scholar
  16. 16.
    Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235:373–382CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Poon RT, Fan ST, Wong J. Risk factors, prevention, management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000, 232:10–24.CrossRefGoogle Scholar
  18. 18.
    Cucchetti A, Piscaglia F, Caturelli E, Benvegnu L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann SurgOncol. 2009;16:413–22Google Scholar
  19. 19.
    Wang J, Li Q, Sun Y, Zheng H, Cui Y, Li H, Zhou H, Hao X. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. Surgical Oncology 2009;18:25–30.CrossRefPubMedGoogle Scholar
  20. 20.
    Makino Y, Yamanoi A, Kimoto T, Nazmy El-Assal O, Kohno H, Nagasue N. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterology 2000;95:1294–1300.CrossRefGoogle Scholar
  21. 21.
    van Gulik TM, de Graaf W, Dinant S, Busch OR, Gouma DJ. Vascular Occlusion Techniques during Liver Resection. Dig Surg 2007; 24:274–281.CrossRefPubMedGoogle Scholar
  22. 22.
    Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115(3):303–9.PubMedGoogle Scholar
  23. 23.
    Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. 1998; Vox Sang 74Suppl 2 315–319.Google Scholar
  24. 24.
    Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE. Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 2007; 31: 2044–2051.CrossRefPubMedGoogle Scholar
  25. 25.
    Goubran H, Sabry W, Kotb R, Seghatchian J, Burnouf T. Platelet microparticles and cancer: an intimate cross-talk. Transfus Apher Sci 2015;53(2):168–172.CrossRefPubMedGoogle Scholar
  26. 26.
    Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21(6):327–348.CrossRefPubMedGoogle Scholar
  27. 27.
    Di Bisceglie AM. Hepatitis B and Hepatocellular Carcinoma.Hepatology2009, 49(5): S56-S60.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.CrossRefPubMedGoogle Scholar
  29. 29.
    Muroyama R, Kato N, Yoshida H, Otsuka M, Moriyama M, Wang Y. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J Hepatol 2006;45:805–812.CrossRefPubMedGoogle Scholar
  30. 30.
    Yu SJ, Kim YJ. Hepatitis B viral load affects prognosis of hepatocellular carcinoma. World J Gastroenterol 2014; 20(34): 12039–12044.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Volpes R, van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology1990; 12: 59–65.CrossRefPubMedGoogle Scholar
  32. 32.
    Sze KM, Chu GK, Lee JM, Ng OL. C-Terminal Truncated Hepatitis B Virus X Protein Is Associated With Metastasis and Enhances Invasiveness by C-Jun/Matrix Metalloproteinase Protein 10 Activation in Hepatocellular Carcinoma. Hepatology 2013;57:131–139.CrossRefPubMedGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2016

Authors and Affiliations

  1. 1.Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations